CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors.
about
CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
CD200-positive cancer associat ...... FR Tyrosine kinase inhibitors.
@ast
CD200-positive cancer associat ...... FR Tyrosine kinase inhibitors.
@en
CD200-positive cancer associat ...... FR Tyrosine kinase inhibitors.
@nl
type
label
CD200-positive cancer associat ...... FR Tyrosine kinase inhibitors.
@ast
CD200-positive cancer associat ...... FR Tyrosine kinase inhibitors.
@en
CD200-positive cancer associat ...... FR Tyrosine kinase inhibitors.
@nl
prefLabel
CD200-positive cancer associat ...... FR Tyrosine kinase inhibitors.
@ast
CD200-positive cancer associat ...... FR Tyrosine kinase inhibitors.
@en
CD200-positive cancer associat ...... FR Tyrosine kinase inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
CD200-positive cancer associat ...... FR Tyrosine kinase inhibitors.
@en
P2093
Atsushi Ochiai
Genichiro Ishii
Hibiki Udagawa
Hiroko Hashimoto
Keisuke Kirita
Kenkichi Masutomi
Kiyotaka Yoh
Koichi Goto
Masahiro Tsuboi
Masayuki Ishibashi
P2860
P2888
P356
10.1038/SREP46662
P407
P577
2017-04-21T00:00:00Z
P6179
1085000642